3625 results for «2066»
3625 results
TAVI in bicuspid aortic valve patients. SAPIEN 3 platform, a safe and efficient option
19 May 2021 – From EuroPCR 2021
Watch this session presented by Philippe Genereux, Didier Tchetche, Joerg Kempfer, Radoslaw Parma and Christoph Klein in order to understand which patients with bicuspid aortic valve are suitable for TAVI vs. SAVR, to learn about Edwards SAPIEN 3 being utilisation in patients with bicuspid aortic valve, and to know more about the...
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort
18 May 2021 – From EuroPCR 2021
Watch this session presented by Ajay Kirtane, Melvin David Lobo and Felix Mahfoud in order to review a history of the field and the recent clinical advancements in renal denervation with the Paradise Ultrasound RDN system, to further examine the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
Introducing Navitor: a new TAVI solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...
Coronary access after TAVI, a growing need
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...
EAPCI-PCR Fellows Course: interventions for calcified coronary lesions
18 May 2021 – From EuroPCR 2021
Watch this session if you want to review the role of imaging for procedural planning and to discuss the best indications for specific plaque modification techniques.
This session was originally presented during EuroPCR 2021.
Redefining hypertension management with renal denervation
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
EuroPCR 2021 Hotlines / Late-Breaking Trials: STS-ACC TVT Registry, AMTRAC, MATCH-BALL, SWENTRY, and ITAL-neo Registry
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TAVI:
- STS/ACC TVT Registry: TAVR for bicuspid aortic valve stenosis in low surgical risk population
- AMTRAC Valve Registry: regression of mitral regurgitation and outcomes following TAVR
- MATCH-BALL study: matched comparison of outcomes with Balloon-Expandable transcatheter heart valve
- SWENTRY registry: radiological predictors...
EuroPCR 2021 Hotlines / Late-Breaking Trials in mitral regurgitation: Spanish National Registry of TMVR and more!
25 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in mitral regurgitation:
- Percutaneous and surgical treatment for post-AMI mitral regurgitation
- Early experience: a new leaflet repair device for mitral/tricuspid regurgitation
- Outcomes of Mitraclip in atrial functional mitral regurgitation
Revisiting DK Crush: key steps and pitfalls
19 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit DK Crush PCI step by step, to review the potential pitfalls of DK Crush, and to visualise the limitations of angiography to accurately assess stent geometry at different steps of the procedure.
This session was originally presented during EuroPCR...
Treatment of uncontrolled hypertension: case-based discussion
19 May 2021 – From EuroPCR 2021
Watch this session if you want to share indications and optimal criteria for patient selection.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 - Innovations in peripheral and structural interventions
18 May 2021 – From EuroPCR 2021
In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.
Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 2)
20 May 2021 – From EuroPCR 2021
This session, which was originally broadcast during EuroPCR 2021, presents 6 cases of unexpected complications of large vessel access in the context of TAVI procedures and enables our experts to discuss their successful management, using a variety of techniques. It highlights the need for a large...
Culotte technique for bifurcation PCI - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss which anatomy is suitable for the culotte stenting technique, to learn the steps of culotte stenting, and to review the pitfalls of culotte stenting.
This session was originally presented during EuroPCR 2021.
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
